Brief: AFT Pharmaceuticals Updates On Programme To Obtain U.S. FDA Registration Of Maxigesic IV

AFT Pharmaceuticals

01/09/2022 22:38

Sept 2 (Reuters) - AFT Pharmaceuticals Ltd  AFT.NZ :
    * UPDATES ON ITS PROGRAMME TO OBTAIN U.S. FDA REGISTRATION
OF
MAXIGESIC IV
    * AFT WILL THEN FILE WITH FDA ONCE STUDIES ARE COMPLETE
    * STUDIES ARE EXPECTED TO COMMENCE BEFORE END OF THIS YEAR
AND ARE
DUE TO COMPLETE IN NEW YEAR

Further company coverage:  AFT.NZ 

 ((Reuters.Briefs@thomsonreuters.com;))